Asenapine Sublingual Tablets 10 mg
ARL/CT/13/003
Phase 3 small_molecule completed
Quick answer
Asenapine Sublingual Tablets 10 mg for Schizophrenia is a Phase 3 program (small_molecule) at Amneal Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amneal Pharmaceuticals
- Indication
- Schizophrenia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed